Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Non-Current Deffered Revenue (2019)

Alx Oncology Holdings' Non-Current Deffered Revenue history spans 1 years, with the latest figure at $135000.0 for Q4 2019.

  • On a quarterly basis, Non-Current Deffered Revenue changed N/A to $135000.0 in Q4 2019 year-over-year; TTM through Dec 2019 was $135000.0, a N/A change, with the full-year FY2019 number at $135000.0, changed N/A from a year prior.
  • Non-Current Deffered Revenue hit $135000.0 in Q4 2019 for Alx Oncology Holdings.
  • Over the last five years, Non-Current Deffered Revenue for ALXO hit a ceiling of $135000.0 in Q4 2019 and a floor of $135000.0 in Q4 2019.